Retension Pharmaceuticals, Inc. (RTSN) vs Seer, Inc. (SEER)

Retension Pharmaceuticals, Inc. RTSN 10.58 −8.79%
Seer, Inc. SEER 1.64 −3.53%

Retension Pharmaceuticals, Inc. and Seer, Inc. are both Biotechnology companies. Retension Pharmaceuticals, Inc. and Seer, Inc. are of similar size ($96.6M and $94.1M).

Metric	RTSN	SEER	Biotechnology median
P/E	—	n/m	10.26
P/S	—	6.36	9.18
P/B	—	0.40	2.05
Price to free cash flow	—	n/m	24.81
EV/EBITDA	—	0.97	0.65
EV/Sales	—	(4.39)	8.98
Earnings yield	—	(74.39%)	(34.89%)
Free cash flow yield	—	(48.61%)	(24.52%)

Metric	RTSN	SEER	Biotechnology median
Gross margin	—	47.70%	65.16%
Operating margin	—	(498.19%)	0.00%
Net margin	—	(478.05%)	0.00%
Free cash flow margin	—	(309.34%)	0.00%
Return on equity	—	(26.45%)	(50.12%)
Return on assets	—	(23.47%)	(45.60%)
Return on invested capital	—	(60.78%)	0.00%

Metric	RTSN	SEER	Biotechnology median
Revenue growth (TTM)	—	(12.71%)	6.26%
EPS growth (last fiscal year)	—	7.91%	29.88%
Revenue growth, 5-year CAGR	—	90.78%	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	RTSN	SEER	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	14.74	4.89
Net debt to EBITDA	—	2.63	1.01

Metric	RTSN	SEER	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	RTSN	SEER	Biotechnology median
Market cap	96.61m	94.13m	172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack